Amplification-Free CRISPR-Cas System Integrated Centrifugal Digital Microfluidic Platform Developed for Multiplexed

Jing Zhang1, Longjie Li1, Yidan Zhu1

  • 1Jiangsu Key Laboratory of Advanced Medical Analysis and Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, Nantong, Jiangsu 226019, P. R. China.

Analytical Chemistry
|November 16, 2025
PubMed
Summary

This study developed a CRISPR-Cas9/Cas13a digital microfluidic chip for rapid, sensitive detection of respiratory pathogens like MRSA and H1N1. The platform offers high accuracy without preamplification, ideal for resource-limited settings.